LEVODOPA/BENSERAZIDE Devatis cpr 250 mg fl 100 pce

7680684720062 CH-68472 N04BA02 01.08.0.
LEVODOPA/BENSERAZIDE Devatis cpr 250 mg fl 100 pce
LEVODOPA/BENSERAZIDE Devatis cpr 250 mg fl 100 pce
LEVODOPA/BENSERAZIDE Devatis cpr 250 mg fl 100 pce
1 / 3
google

Details

Product number
6847203
CPT
-
Packaging group
100
Unit
Tablette(n)
Composition
benserazidum 50 mg ut benserazidi hydrochloridum, levodopum 200 mg, natrii docusas, E 172 (rubrum), ethylcellulosum, silica colloidalis anhydrica, cellulosum microcristallinum, amylum pregelificatum, mannitolum, calcii hydrogenophosphas, crospovidonum, magnesii stearas, pro compresso corresp. natrium 0.01035 mg.

Articles (1)

Levodopa / Benserazid Devatis 250 mg (200 mg + 50 mg), Tabletten
Tabletten
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
26/02/2024
Professional SmPC
Français
26/02/2024
Professional SmPC
Italien
26/02/2024
Patient information leaflet
Allemand
10/01/2022
Patient information leaflet
Français
10/01/2022
Patient information leaflet
Italien
10/01/2022

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.01035 MG Substance HBESI

Reimbursement information

Public price
CHF 35.40
Specialties list
Yes
Generic
Yes
SL addition date: 01/05/2022

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
68472
Drug name
Levodopa / Benserazid Devatis, Tabletten
Galenic form
TAB
ATC Code
N04BA02
Authorization status
Z
Dispensation category
B
First authorization
01/12/2021
Authorization expiration date
30/11/2026
IT number
01.08.0.
Domain
Human medicine
Field of application
Morbus Parkinson, Restless Legs-Syndrom

Packaging details

Description (FR)
LEVODOPA/BENSERAZIDE Devatis cpr 250 mg fl 100 pce
Description (DE)
LEVODOPA/BENSERAZID Devatis Tabl 250 mg Fl 100 Stk
Market launch
01/12/2021
Narcotic (BTM)
No

Original drug

Duodopa, Gel zur intestinalen Anwendung
CHF 457.25
View original

Other packaging sizes

LEVODOPA/BENSERAZIDE Devatis cpr 62.5 mg 30 pce
30 TABL
View
LEVODOPA/BENSERAZIDE Devatis cpr 62.5 mg 100 pce
100 TABL
View
LEVODOPA/BENSERAZIDE Devatis cpr 125 mg fl 30 pce
30 TABL
View
LEVODOPA/BENSERAZIDE Devatis cpr 125 mg fl 100 pce
100 TABL
View
LEVODOPA/BENSERAZIDE Devatis cpr 250 mg fl 30 pce
30 TABL
View